|
1
|
Pavenstadt H, Kriz W and Kretzler M: Cell
biology of the glomerular podocyte. Physiol Rev. 83:253–307. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shankland SJ and Al'Douahji M: Cell cycle
regulatory proteins in glomerular disease. Exp Nephrol. 7:207–211.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu C, Xuan X, Che R, Ding G, Zhao M, Bai
M, Jia Z, Huang S and Zhang A: Dysfunction of the
PGC-1α-mitochondria axis confers adriamycin-induced podocyte
injury. Am J Physiol Renal Physiol. 306:F1410–F1417. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maezawa Y, Onay T, Scott RP, Keir LS,
Dimke H, Li C, Eremina V, Maezawa Y, Jeansson M, Shan J, et al:
Loss of the podocyte expressed transcription factor Tcf21/Pod1
results in podocyte differentiation defects and FSGS. J Am Soc
Nephrol. 25:2459–2470. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanamura K, Tojo A and Fujita T: Urinary
and glomerular podocytes in patients with chronic kidney diseases.
Clin Exp Nephrol. 18:95–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takeda A, Ohgushi H, Niimura F and
Matsutani H: Long-term effects of immunosuppressants in
steroid-dependent nephrotic syndrome. Pediatr Nephrol. 12:746–750.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hogan J and Radhakrishnan J: The treatment
of minimal change disease in adults. J Am Soc Nephrol. 24:702–711.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shahzad M, Shabbir A, Wojcikowski K,
Wohlmuth H and Gobe GC: The Antioxidant effects of radix astragali
(astragalus membranaceus and related species) in protecting tissues
from injury and disease. Curr Drug Targets. 17:1331–1340. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu G, Song J, Guo Y, Wang T and Zhou Z:
Astragalus injection protects cerebral ischemic injury by
inhibiting neuronal apoptosis and the expression of JNK3 after
cerebral ischemic reperfusion in rats. Behav Brain Funct. 9:362013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng M, Yuan W, Zhang R, Fu P and Wu T:
Chinese herbal medicine Huangqi type formulations for nephrotic
syndrome. Cochrane Database Syst Rev. 6:Cd0063352013.
|
|
11
|
Korbet SM: Treatment of primary FSGS in
adults. J Am Soc Nephrol. 23:1769–1776. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan W, Wang J and Wu T: Chinese herbal
medicine Huangqi type formulations for nephrotic syndrome. Cochrane
Database Syst Rev. 2:Cd0063352008.
|
|
13
|
Xu M, Yin J, Xie L, Zhang J, Zou C, Zou J,
Liu F, Ju W and Li P: Pharmacokinetics and tolerance of toal
astragalosides after intravenous infusion of astragalosides
injection in healthy Chinese volunteers. Phytomedicine.
20:1105–1111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang N, Wei RB, Li QP, Yang X and Chen X:
Protective effects of astragaloside in rats with adriamycin
nephropathy and underlying mechanism. Chin J Nat Med. 14:270–277.
2016.PubMed/NCBI
|
|
15
|
Bertani T, Poggi A, Pozzoni R, Delaini F,
Sacchi G, Thoua Y, Mecca G, Remuzzi G and Donati MB:
Adriamycin-induced nephrotic syndrome in rats: Sequence of
pathologic events. Lab Invest. 46:16–23. 1982.PubMed/NCBI
|
|
16
|
Yi M, Zhang L, Liu Y, Livingston MJ, Chen
JK, Nahman NS Jr, Liu F and Dong Z: Autophagy is activated to
protect against podocyte injury in adriamycin-induced nephropathy.
Am J Physiol Renal Physiol. 313:F74–F84. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Saito Y, Okamura M, Nakajima S, Hayakawa
K, Huang T, Yao J and Kitamura M: Suppression of nephrin expression
by TNF-alpha via interfering with the cAMP-retinoic acid receptor
pathway. Am J Physiol Renal Physiol. 298:1436–1444. 2010.
View Article : Google Scholar
|
|
18
|
Zhang HT, Wang WW, Ren LH, Zhao XX, Wang
ZH, Zhuang DL and Bai YN: The mTORC2/Akt/NFκB pathway-mediated
activation of TRPC6 participates in adriamycin-induced podocyte
apoptosis. Cell Physiol Biochem. 40:1079–1093. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang N, Wei RB, Li P, Li QP, Yang X, Yang
Y, Huang MJ, Wang R, Yin Z, Lv Y and Chen XM: Treatment with
irbesatan may improve slit diaphragm alterations in rats with
adriamycin-inducednephropathy. J Renin Angiotensin Aldosterone
Syst. 17:14703203166468842016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Susztak K, Raff AC, Schiffer M and
Böttinger EP: Glucose-induced reactive oxygen species cause
apoptosis of podocytes and podocyte depletion at the onset of
diabetic nephropathy. Diabetes. 55:225–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Asanuma K, Yanagida-Asanuma E, Faul C,
Tomino Y, Kim K and Mundel P: Synaptopodin orchestrates actin
organization and cell motility via regulation of RhoA signaling.
Nat Cell Biol. 8:485–491. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lei FY, Zhou TB, Qin YH, Chen XP and Li
ZY: Potential signal pathway of all-trans retinoic acid for MMP-2
and MMP-9 expression in injury podocyte induced by adriamycin. J
Recept Signal Transduct Res. 34:378–385. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Merkle M, Ribeiro A, Köppel S and Wörnle
M: TNF-α enhances TLR3-dependent effects on MMP-9 expression in
human mesangial cells. Cell Biol Int. 36:1155–1160. 2012.
View Article : Google Scholar : PubMed/NCBI
|
